NCT07145307
Personalized Digital Treatment for Adolescent Anxiety: A Feasibility Trial
At risk: Primary completion moved at least 5 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 9 words
- Primary completion pushed from Oct 2026 to Apr 2027
- Study completion date: Mar 2027 to Apr 2027
- Study description expanded, about 2 words
- Notable Trial status: Not Yet Recruiting to Recruiting
- Study sites: 1 to 2
- Primary completion date: Sep 2026 to Oct 2026
- Start date changed from estimate of Aug 2025 to Oct 20, 2025
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Sidekick app engagement and completion of tasks
Timeframe: From pre-treatment/baseline to post-treatment (variable and participant-dependent, estimated range: 4-12 weeks)
Credibility and Expectancy Questionnaire (CEQ-1)
Timeframe: At post-treatment (variable and participant-dependent, estimated range: 4-12 weeks post-baseline)
Client Satisfaction Questionnaire (CSQ-3)
Timeframe: At post-treatment (variable and participant-dependent, estimated range: 4-12 weeks post-baseline)
EuroQoL 5D-5L (EQ-5D-5L)
Timeframe: At pre-treatment/baseline and post-treatment (variable and participant-dependent, estimated range: 4-12 weeks post-baseline)
Level of anxiety before, during and after exposure tasks
Timeframe: From pre-treatment/baseline to post-treatment (variable and participant-dependent, estimated range: 4-12 weeks) after every completed exposure task (variable and participant-dependent, estimated range: 1-20 exposure tasks per month)
Recruitment
Timeframe: At pre-treatment/baseline.
Adherence
Timeframe: From pre-treatment/baseline to post-treatment (variable and participant-dependent, estimated range: 4-12 weeks post-baseline), and from post-treatment to 3-month follow-up.
Qualitative interviews
Timeframe: At post-treatment (variable and participant-dependent, estimated range: 4-12 weeks post-baseline).
Revised Child Anxiety and Depression Scale (RCADS 47)
Timeframe: At pre-treatment/baseline, post-treatment (variable and participant-dependent, estimated range: 4-12 weeks post-baseline), and 3-month follow-up.
General self-efficacy scale (GSES)
Timeframe: At pre-treatment/baseline, post-treatment (variable and participant-dependent, estimated range: 4-12 weeks post-baseline), and 3-month follow-up.
KIDSCREEN-10
Timeframe: At pre-treatment/baseline, post-treatment (variable and participant-dependent, estimated range: 4-12 weeks post-baseline), and 3-month follow-up.
Patient Exposure and Response Prevention Adherence Scale (PEAS)
Timeframe: From pre-treatment/baseline to post-treatment (variable and participant-dependent, estimated range: 4-12 weeks) after every completed exposure task (variable and participant-dependent, estimated range: 1-20 exposure tasks per month)
Arms and interventions
SidekickExperimental
Use of the Sidekick app as an ad-on to regular outpatient treatment.
Devices: Sidekick
Sites
2 sites in 1 country